..
原稿を提出する arrow_forward arrow_forward ..

音量 12, 問題 6 (2022)

意見

Progress in Research on Rehabilitation Following Knee Autologous Chondrocyte Transplantation

Arnaud Gregoire*

We combined participant-level data from 524 patients across twenty-two eligible clinical trials that met our inclusion criteria. The type and source of the infused cells had a significant impact on the outcome. 58.9 percent of T1DM patients who received CD34+ hematopoietic stem cell (HSC) infusions became insulin-independent for a mean of 16 months, whereas patients who received umbilical cord blood (UCB) consistently failed. When compared to bone marrow mesenchymal stem cells (BM-MSCs), infusion of umbilical cord mesenchymal stem cells (UC-MSCs) significantly improved T1DM outcomes (P 0.0001 and P=0.1557). Early stem cell therapy administration was more effective than later intervention (relative risk=2.0, P=0.0008) after DM diagnosis. Unfriendly impacts were seen in just 21.72% of both T1DM and T2DM foundational microorganism beneficiaries with no detailed mortality. Diabetes ketoacidosis was identified in 79.5% of the poor responders.

ミニレビュー

Bone Marrow Transplantation Animal Models

Mehdi Bendjelloul*

We combined participant-level data from 524 patients across twenty-two eligible clinical trials that met our inclusion criteria. The type and source of the infused cells had a significant impact on the outcome. 58.9 percent of T1DM patients who received CD34+ hematopoietic stem cell (HSC) infusions became insulin-independent for a mean of 16 months, whereas patients who received umbilical cord blood (UCB) consistently failed. When compared to bone marrow mesenchymal stem cells (BM-MSCs), infusion of umbilical cord mesenchymal stem cells (UC-MSCs) significantly improved T1DM outcomes (P 0.0001 and P=0.1557). Early stem cell therapy administration was more effective than later intervention (relative risk=2.0, P=0.0008) after DM diagnosis. Unfriendly impacts were seen in just 21.72% of both T1DM and T2DM foundational microorganism beneficiaries with no detailed mortality. Diabetes ketoacidosis was identified in 79.5% of the poor responders.

ミニレビュー

A Functioning and Vascularized Human Brain Organoids

Ville Sallinen*

An unprecedented opportunity exists to simulate human brain development and disease by dividing human pluripotent stem cells into tiny brainlike organoids. We developed a technique for transplanting human brain organoids into adult mouse brains in order to provide a vascularized and functional in vivo model of brain organoids. Organoid joins showed moderate neuronal separation and development, gliogenesis, combination of microglia and development of axons to various areas of the host cerebrum. Two-photon in vivo imaging revealed the grafts' functional neuronal networks and blood vessels. Finally, optogenetics and in vivo extracellular recording revealed intragraft neuronal activity and suggested functional synaptic connectivity between the host and the graft. It's possible that disease modeling under physiological conditions will be made easier by combining human neural organoids with an in vivo physiological environment in the animal brain.

インデックス付き

arrow_upward arrow_upward